• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:陈志军,高文远,王颖.胰岛素泵治疗2型糖尿病的药物经济学评价[J].中国现代应用药学,2012,29(4):367-370.
CHEN Zhijun, GAO Wenyuan, WANG Ying.Analysis on Pharmaceutical Economics of Continuous Subcutaneous Insulin Injection for Treating Type-2 Diabetes Mellitus[J].Chin J Mod Appl Pharm(中国现代应用药学),2012,29(4):367-370.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2619次   下载 3078 本文二维码信息
码上扫一扫!
分享到: 微信 更多
胰岛素泵治疗2型糖尿病的药物经济学评价
陈志军,高文远,王颖1,2
1.天津大学药物科学与技术学院,,天津 300072;2.中国人民武装警察部队医学院附属医院,天津 300162
摘要:
目的 比较胰岛素泵和传统皮下强化注射胰岛素治疗2型糖尿病的成本效果。方法 将115例2型糖尿病住院患者分成2组,一组住院过程中使用胰岛素泵治疗(A组)58例,另一组强化皮下注射胰岛素(B组)57例,1周后观察2组的降糖效果。采用成本-效果分析法对2组患者进行分析,效果指标选择血糖降低有效率。结果 A组的成本为616.6元,有效率为96.6%;B组的成本为512.2元,有效率为91.2%,A组的成本效果比(C/E)为6.38,B组的C/E为5.62。A组与B组相比,每增加一单位有效率,需要增加成本1 933.33元。结论 强化皮下注射胰岛素治疗2型糖尿病具有较好的绝对经济效率,但与胰岛素泵治疗相比,后者具有较好的增量成本效果比。
关键词:  胰岛素泵  2型糖尿病  成本-效果分析
DOI:
分类号:
基金项目:
Analysis on Pharmaceutical Economics of Continuous Subcutaneous Insulin Injection for Treating Type-2 Diabetes Mellitus
CHEN Zhijun, GAO Wenyuan, WANG Ying1,2
1.School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China;2.The Affiliated Hospital of Medical College of Chinese People’s Armed Police Forces, Tianjin 300162, China
Abstract:
OBJECTIVE To compare the economical effectiveness of continuous subcutaneous insulin injection(group A) and multiple daily injection(group B) for treating type-2 diabetes mellitus. METHODS Using cost-effectiveness analysis(CEA) on pharmaceutical economics to compare the cost effectiveness of the group A and group B. RESULTS The cost for group A and B were 616.6 and 512.2 Yuan, respectively. The total effective rates of controlling blood glucose were 96.6% and 91.2%, respectively. The cost-effectiveness ratios were 6.38 and 5.62, respectively. To increase one unit effective rate in group A need to raise the cost of 1 933.33 Yuan. CONCLUSION Group B has higher absolute economic efficiency for the treatment of type-2 diabetes. But group A has higher incremental cost effectiveness ratio than group B.
Key words:  continuous subcutaneous insulin injection  type-2 diabetes mellitus  cost-effectiveness analysis
扫一扫关注本刊微信